However, considering post-stroke changes in the proportion of T cells, with a predominance of CD4+ T cells, especially the neuroprotective type of CD4+ T cells—Th2 type (Prass et al., 2003) our findings may confirm the potential benefits of this phenomenon. This evidence concerns the gene CD4 and stroke disorder.